Earnings History Data for ImmuCell Corporation (ICCC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ImmuCell Corporation

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 AH ICCC ImmuCell Corporation 39.84 -0.15 0.00 -0.22 ImmuCell GAAP EPS of -$0.15, revenue of $5.09M
[2/27/2024 4:23 PM]
5.22 0.08 
(1.56%)
0.0 0.0 
(0.00%)
4.26 - 6.16 7,570 10,000 0
13-11-2023 AH ICCC ImmuCell Corporation 42.30 -0.12 0.00 -0.08 ImmuCell GAAP EPS of -$0.12, revenue of $5.39M
[11/13/2023 4:23 PM]
5.30 0.10 
(1.92%)
0.0 0.0 
(0.00%)
4.26 - 8.48 9,269 10,000 0
11-05-2023 AH 4:05 PM ET
(May 11)
ICCC ImmuCell Corporation 37.96 -0.30 0.00 0.09 ImmuCell GAAP EPS of -$0.30, revenue of $2.6M
[5/11/2023 4:29 PM]
4.64 -0.32 
(-6.46%)
4.61 -0.35 
(-7.06%)
4.26 - 9.60 26,636 0 147
21-02-2023 AH 4:05 PM ET
(Feb 21)
ICCC ImmuCell Corporation 55.39 -0.22 0.00 0.01 ImmuCell GAAP EPS of -$0.32, revenue of $18.57M
[2/21/2023 4:24 PM]
6.81 -0.50 
(-6.84%)
0.0 0.0 
(0.00%)
5.98 - 10.96 25,527 10,000 0
11-08-2022 AH 4:05 PM ET
(Aug 11)
ICCC ImmuCell Corporation 65.19 -0.09 0.00 0.02 ImmuCell GAAP EPS of -$0.09, revenue of $3.86M
[8/11/2022 4:26 PM]
8.15 -0.60 
(-6.86%)
0.0 0.0 
(0.00%)
7.30 - 10.96 37,833 10,000 0
12-05-2022 AH 4:05 PM ET
(May 13)
ICCC ImmuCell Corporation 62.02 0.09 0.00 -0.06 ImmuCell reports Q1 results
[5/12/2022 4:11 PM]
8.29 0.49 
(6.30%)
7.82 0.02 
(0.26%)
7.30 - 10.96 9,569 20,000 513
22-02-2022 AH 4:05 PM ET
(Feb 22)
ICCC ImmuCell Corporation 65.50 0.01 0.00 0.03 ImmuCell GAAP EPS of -$0.01 beats by $0.10, revenue of $19.24M beats by $2.59M
[2/22/2022 4:43 PM]
8.11 0.11 
(1.40%)
0.0 0.0 
(0.00%)
7.30 - 12.02 8,637 10,000 0
15-11-2021 AH 4:05 PM ET
(Nov 15)
ICCC ImmuCell Corporation 71.30 0.02 0.00 -0.04 ImmuCell reports Q3 results
[11/15/2021 4:26 PM]
9.20 0.0 
(0.00%)
0.0 0.0 
(0.00%)
5.41 - 13.20 7,525 0 0
12-08-2021 AH 4:05 PM ET
(Aug 12)
ICCC ImmuCell Corporation 73.53 0.02 0.00 -0.11 ImmuCell reports Q2 results
[8/12/2021 4:41 PM]
9.01 -0.33 
(-3.49%)
0.0 0.0 
(0.00%)
5.01 - 13.20 11,805 0 0
13-05-2021 AH 4:00 PM ET
(May 13)
ICCC ImmuCell Corporation 72.72 -0.06 0.00 -0.02 ImmuCell reports Q1 results
[5/13/2021 4:15 PM]
9.78 0.57 
(6.19%)
0.0 0.0 
(0.00%)
3.80 - 13.20 17,890 20,000 0
22-02-2021 AH 4:05 PM ET
(Feb 22)
ICCC ImmuCell Corporation 82.37 0.03 0.00 -0.06 ImmuCell EPS beats by $0.10, beats on revenue
[2/22/2021 4:06 PM]
10.47 -1.27 
(-10.82%)
11.00 -0.74 
(-6.30%)
3.70 - 13.20 107,684 54,805 1,430
12-11-2020 AH 4:05 PM ET
(Nov 12)
ICCC ImmuCell Corporation 39.45 -0.04 0.00 -0.07 ImmuCell EPS beats by $0.04, beats on revenue
[11/12/2020 4:14 PM]
5.75 0.07 
(1.23%)
0.0 0.0 
(0.00%)
3.70 - 8.13 12,013 9,018 0
12-08-2020 AH 4:05 PM ET
(Aug 12)
ICCC ImmuCell Corporation 41.76 -0.11 0.00 -0.09 ImmuCell EPS misses by $0.01, misses on revenue
[8/12/2020 4:07 PM]
5.55 -0.15 
(-2.63%)
0.0 0.0 
(0.00%)
3.70 - 8.13 9,291 18,497 0